These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29233639)

  • 1. Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Rasool I; Afroze D; Wani KA; Yousuf A; Bhat IA; Rah B; Nazir SU; Hussain S; Dubey S
    Clin Breast Cancer; 2018 Aug; 18(4):e671-e676. PubMed ID: 29233639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Motawi TMK; Zakhary NI; Darwish HA; Abdalla HM; Tadros SA
    Clin Breast Cancer; 2019 Apr; 19(2):e276-e282. PubMed ID: 30765238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immunohistochemical expression of survivin and its correlation with -31G/C gene polymorphism in colorectal cancer.
    Heidari Z; Sagheb HM; Hakimi A; Moudi B
    Med Mol Morphol; 2019 Jun; 52(2):82-89. PubMed ID: 30128768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
    Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
    PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
    Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
    Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
    Jaiswal PK; Goel A; Mandhani A; Mittal RD
    Mol Biol Rep; 2012 May; 39(5):5615-21. PubMed ID: 22193624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
    Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
    J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
    Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
    Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
    Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
    BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
    Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
    Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between rs9904341 GQin L; Yu T
    Genet Mol Res; 2015 May; 14(2):5197-202. PubMed ID: 26125713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
    Srivastava K; Srivastava A; Mittal B
    Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between survivin genetic polymorphisms and lung cancer susceptibility.
    Guo G; Zhang Q; Yu Z; Li J; Ding Z; Li J; Tan W
    Int J Clin Exp Pathol; 2015; 8(6):7426-30. PubMed ID: 26261647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin c.-31G>C (rs9904341) gene transversion and urinary system cancers risk: a systematic review and a meta-analysis.
    Mazoochi T; Karimian M; Ehteram H; Karimian A
    Per Med; 2019 Jan; 16(1):67-78. PubMed ID: 30465472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population.
    Yang L; Zhu H; Zhou B; Gu H; Yan H; Tang N; Dong H; Sun Q; Cong R; Chen G; Wang B
    Dig Dis Sci; 2009 May; 54(5):1021-8. PubMed ID: 18716870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India.
    Devi KR; Ahmed J; Narain K; Mukherjee K; Majumdar G; Chenkual S; Zonunmawia JC
    Technol Cancer Res Treat; 2017 Dec; 16(6):1150-1159. PubMed ID: 29332455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the survivin gene and the risk of lung cancer.
    Jang JS; Kim KM; Kang KH; Choi JE; Lee WK; Kim CH; Kang YM; Kam S; Kim IS; Jun JE; Jung TH; Park JY
    Lung Cancer; 2008 Apr; 60(1):31-39. PubMed ID: 17961802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.